Skip to content

Collaborative-care Rehabilitation After Dysvascular Amputation

Collaborative-care Rehabilitation to Improve Functional Outcomes After Dysvascular Amputation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01929018
Enrollment
38
Registered
2013-08-27
Start date
2013-10-09
Completion date
2017-06-29
Last updated
2019-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Complications, Peripheral Arterial Disease

Keywords

Amputation, Rehabilitation, Exercise, Movement

Brief summary

The objective of this study is to examine the feasibility of using a collaborative-care, home-based rehabilitation program to improve functional outcomes for people recovering from lower limb amputation caused by vascular problems and/or diabetes complications. The primary hypothesis is that the rehabilitation program will result in greater improvements in performance-based and participant-reported measures of physical function, compared to standard of care after outpatient rehabilitation.

Interventions

BEHAVIORALExercise

Exercise will target muscle strength and joint mobility impairments and will be delivered over a 12 week period.

BEHAVIORALWalking Program

A walking program will be established with the goal of participants walking at least five days per week. Duration of program is 12 weeks.

BEHAVIORALHealth Self-Management Support

Health self-management support will be delivered with weekly meetings between the researcher and participant over a 12-week period.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Diabetes and/or Peripheral Artery Disease 2. Unilateral transtibial amputation \< 6 months prior to screening 3. Household ambulation using definitive prosthesis prior to baseline testing 4. Participation in physical rehabilitation at time of baseline testing 5. Live within 45 minutes of a participating clinic

Exclusion criteria

1. Require wheelchair for mobility (use prosthesis for transfers only) 2. Ankle-level or above amputation on contralateral limb 3. Traumatic or cancer-related amputation 4. Uncontrolled heart condition 5. Acute systemic infection 6. Pregnancy 7. Decisionally challenged 8. Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Timed Up-and-Go TestBaseline, 12-weeks, and 24 weeksPerformance-based physical function test able to predict falls for people with lower limb amputation. The TUG test time is taken from rising from a chair, walking 3 meters, turning, walking back and sitting down. Continuous scale; higher time indicates lower physical function, higher likelihood of falls.

Secondary

MeasureTime frameDescription
Five Meter Walk TestBaseline, 12 weeks, and 24 weeksPerformance-based physical function test measures the time to walk 5 meters at the participant's normal, everyday pace.
Prosthesis Evaluation Questionnaire - Mobility SectionBaseline, 12 weeks, and 24 weeksSelf-report physical function questionnaire measures capacity to perform a list of specific functional tasks (e.g., walking upstairs, getting in and out of a vehicle. Scores range from being unable or hardly able (0) to having no problems (4). An average score across the 12-item questionnaire was used in the analysis. Lower numbers indicate less difficulty.
Houghton ScaleBaseline, 12 weeks, and 24 weeksSelf-report physical function questionnaire. The outcome is the sum of scores from each item (min 0, max 12). A higher score indicates higher self-report of physical function with the prosthesis.
Two-Minute Walk TestBaseline, 12 weeks, and 24 weeksPerformance-based physical function test measures total number of meters walked in two minutes on a level walkway.
Physical Activity Step CountsBaseline, 12 weeks, and 24 weeksInstrumented physical activity measure, average step counts per day
Self-Efficacy in Managing Chronic Disease QuestionnaireBaseline, 12 weeks, and 24 weeksScale range is 1-10. The score for the scale is the mean of the six items, using a ten point scale. Higher number indicates higher self-efficacy.
World Health Organization Disability Assessment ScaleBaseline, 12 weeks, and 24 weeksScores ranging from 1 (no difficulty) to 5 (extreme difficulty/cannot do). Overall disability was calculated by summing the scores for the 12 items; higher scores indicated greater disability (score range: 12-60).
Patient-Specific Function ScaleBaseline, 12 weeks, and 24 weeksSelf-report physical function questionnaire. The outcome is the average score for up to five participant-identified activities on a scale from 0-10 (min 0, max 10). Higher score indicates greater ability to perform functional activities.

Countries

United States

Participant flow

Pre-assignment details

No significant study events occurred after participants were enrolled, but before they were assigned to a study group.

Participants by arm

ArmCount
Exercise, Activity, and Self-management
Exercise, Walking Program, and Health Self-Management Support. Participants will be visited at home once monthly and contacted by phone once weekly over 12 weeks to deliver the interventions. Exercise: Exercise will target muscle strength and joint mobility impairments and will be delivered over a 12 week period. Walking Program: A walking program will be established with the goal of participants walking at least five days per week. Duration of program is 12 weeks. Health Self-Management Support: Health self-management support will be delivered with weekly meetings between the researcher and participant over a 12-week period.
19
Home and Phone Visit
No intervention will be applied. Participants will be visited at home once monthly and contacted by phone once weekly over 12 weeks to monitor health status.
19
Total38

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyHospitalization01
Overall StudyLost to Follow-up10

Baseline characteristics

CharacteristicExercise, Activity, and Self-managementHome and Phone VisitTotal
Age, Continuous62 Years
STANDARD_DEVIATION 6
65 Years
STANDARD_DEVIATION 11.3
63.6 Years
STANDARD_DEVIATION 9.1
BMI, kg/m231 kg/m^2
STANDARD_DEVIATION 10.6
30 kg/m^2
STANDARD_DEVIATION 6.3
31 kg/m^2
STANDARD_DEVIATION 8.6
Chakrabarty Grade, score out of 10077.3 units on a scale
STANDARD_DEVIATION 16.2
82.4 units on a scale
STANDARD_DEVIATION 15
79.8 units on a scale
STANDARD_DEVIATION 15.6
Comorbidity Index, score out of 206.1 units on a scale
STANDARD_DEVIATION 2.7
7.1 units on a scale
STANDARD_DEVIATION 2.3
6.6 units on a scale
STANDARD_DEVIATION 2.5
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants3 Participants6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
15 Participants16 Participants31 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Geriatric Depression Scale, score out of 152.8 units on a scale
STANDARD_DEVIATION 3.2
3.2 units on a scale
STANDARD_DEVIATION 2.6
3.0 units on a scale
STANDARD_DEVIATION 2.9
Intrinsic Motivation Inventory, score out of 75.6 units on a scale
STANDARD_DEVIATION 1
5.6 units on a scale
STANDARD_DEVIATION 1.1
5.6 units on a scale
STANDARD_DEVIATION 1.1
Mini Mental Status Exam, score out of 3028.6 units on a scale
STANDARD_DEVIATION 1.2
27.5 units on a scale
STANDARD_DEVIATION 2.5
28.2 units on a scale
STANDARD_DEVIATION 2.1
Region of Enrollment
United States
19 Participants19 Participants38 Participants
Sex: Female, Male
Female
3 Participants0 Participants3 Participants
Sex: Female, Male
Male
16 Participants19 Participants35 Participants
Site of Rehab, n, Veterans Administration Medical Center10 Participants10 Participants20 Participants
Time Since Amputation, weeks16 weeks
STANDARD_DEVIATION 6.5
20 weeks
STANDARD_DEVIATION 6.4
18 weeks
STANDARD_DEVIATION 6.6

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 19
other
Total, other adverse events
14 / 1911 / 19
serious
Total, serious adverse events
4 / 199 / 19

Outcome results

Primary

Timed Up-and-Go Test

Performance-based physical function test able to predict falls for people with lower limb amputation. The TUG test time is taken from rising from a chair, walking 3 meters, turning, walking back and sitting down. Continuous scale; higher time indicates lower physical function, higher likelihood of falls.

Time frame: Baseline, 12-weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)
Exercise, Activity, and Self-managementTimed Up-and-Go TestBaseline19.4 seconds
Exercise, Activity, and Self-managementTimed Up-and-Go Test12-Week18.2 seconds
Exercise, Activity, and Self-managementTimed Up-and-Go Test24-week16.7 seconds
Home and Phone VisitTimed Up-and-Go TestBaseline20.7 seconds
Home and Phone VisitTimed Up-and-Go Test12-Week18.8 seconds
Home and Phone VisitTimed Up-and-Go Test24-week21.3 seconds
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.87Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.38Mixed Models Analysis
Secondary

Five Meter Walk Test

Performance-based physical function test measures the time to walk 5 meters at the participant's normal, everyday pace.

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)
Exercise, Activity, and Self-managementFive Meter Walk Test24-Week0.97 meters/second
Exercise, Activity, and Self-managementFive Meter Walk TestBaseline0.78 meters/second
Exercise, Activity, and Self-managementFive Meter Walk Test12-Week0.96 meters/second
Home and Phone VisitFive Meter Walk TestBaseline0.76 meters/second
Home and Phone VisitFive Meter Walk Test12-Week0.83 meters/second
Home and Phone VisitFive Meter Walk Test24-Week0.86 meters/second
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.11Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.23Mixed Models Analysis
Secondary

Houghton Scale

Self-report physical function questionnaire. The outcome is the sum of scores from each item (min 0, max 12). A higher score indicates higher self-report of physical function with the prosthesis.

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise, Activity, and Self-managementHoughton ScaleBaseline0.64 units on a scaleStandard Deviation 0.15
Exercise, Activity, and Self-managementHoughton Scale12-Week0.69 units on a scaleStandard Deviation 0.28
Exercise, Activity, and Self-managementHoughton Scale24-Week0.77 units on a scaleStandard Deviation 0.18
Home and Phone VisitHoughton ScaleBaseline0.62 units on a scaleStandard Deviation 0.23
Home and Phone VisitHoughton Scale12-Week0.69 units on a scaleStandard Deviation 0.24
Home and Phone VisitHoughton Scale24-Week0.65 units on a scaleStandard Deviation 0.27
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.83Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.13Mixed Models Analysis
Secondary

Patient-Specific Function Scale

Self-report physical function questionnaire. The outcome is the average score for up to five participant-identified activities on a scale from 0-10 (min 0, max 10). Higher score indicates greater ability to perform functional activities.

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise, Activity, and Self-managementPatient-Specific Function ScaleBaseline3.3 units on a scaleStandard Deviation 1.8
Exercise, Activity, and Self-managementPatient-Specific Function Scale12 weeks5.7 units on a scaleStandard Deviation 2.6
Exercise, Activity, and Self-managementPatient-Specific Function Scale24 weeks6.9 units on a scaleStandard Deviation 2.3
Home and Phone VisitPatient-Specific Function ScaleBaseline3.5 units on a scaleStandard Deviation 1.9
Home and Phone VisitPatient-Specific Function Scale12 weeks5.1 units on a scaleStandard Deviation 2.3
Home and Phone VisitPatient-Specific Function Scale24 weeks5.3 units on a scaleStandard Deviation 2.3
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.03t-test, 2 sided
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.02t-test, 2 sided
Secondary

Physical Activity Step Counts

Instrumented physical activity measure, average step counts per day

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)
Exercise, Activity, and Self-managementPhysical Activity Step CountsBaseline1305 average steps per day
Exercise, Activity, and Self-managementPhysical Activity Step Counts12-Week2439 average steps per day
Exercise, Activity, and Self-managementPhysical Activity Step Counts24-Week2294 average steps per day
Home and Phone VisitPhysical Activity Step CountsBaseline1369 average steps per day
Home and Phone VisitPhysical Activity Step Counts12-Week1512 average steps per day
Home and Phone VisitPhysical Activity Step Counts24-Week1510 average steps per day
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.03Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.06Mixed Models Analysis
Secondary

Prosthesis Evaluation Questionnaire - Mobility Section

Self-report physical function questionnaire measures capacity to perform a list of specific functional tasks (e.g., walking upstairs, getting in and out of a vehicle. Scores range from being unable or hardly able (0) to having no problems (4). An average score across the 12-item questionnaire was used in the analysis. Lower numbers indicate less difficulty.

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)
Exercise, Activity, and Self-managementProsthesis Evaluation Questionnaire - Mobility SectionBaseline2.2 units on a scale
Exercise, Activity, and Self-managementProsthesis Evaluation Questionnaire - Mobility Section12-Week2.6 units on a scale
Exercise, Activity, and Self-managementProsthesis Evaluation Questionnaire - Mobility Section24-Week2.7 units on a scale
Home and Phone VisitProsthesis Evaluation Questionnaire - Mobility SectionBaseline2.1 units on a scale
Home and Phone VisitProsthesis Evaluation Questionnaire - Mobility Section12-Week2.0 units on a scale
Home and Phone VisitProsthesis Evaluation Questionnaire - Mobility Section24-Week2.4 units on a scale
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.27Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.58Mixed Models Analysis
Secondary

Self-Efficacy in Managing Chronic Disease Questionnaire

Scale range is 1-10. The score for the scale is the mean of the six items, using a ten point scale. Higher number indicates higher self-efficacy.

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)
Exercise, Activity, and Self-managementSelf-Efficacy in Managing Chronic Disease QuestionnaireBaseline7.6 units on a scale
Exercise, Activity, and Self-managementSelf-Efficacy in Managing Chronic Disease Questionnaire12-Week7.8 units on a scale
Exercise, Activity, and Self-managementSelf-Efficacy in Managing Chronic Disease Questionnaire24-Week8.1 units on a scale
Home and Phone VisitSelf-Efficacy in Managing Chronic Disease QuestionnaireBaseline7.5 units on a scale
Home and Phone VisitSelf-Efficacy in Managing Chronic Disease Questionnaire12-Week7.9 units on a scale
Home and Phone VisitSelf-Efficacy in Managing Chronic Disease Questionnaire24-Week7.5 units on a scale
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.62Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.4Mixed Models Analysis
Secondary

Two-Minute Walk Test

Performance-based physical function test measures total number of meters walked in two minutes on a level walkway.

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)
Exercise, Activity, and Self-managementTwo-Minute Walk TestBaseline86.9 meters
Exercise, Activity, and Self-managementTwo-Minute Walk Test12-Week88.5 meters
Exercise, Activity, and Self-managementTwo-Minute Walk Test24-Week99.8 meters
Home and Phone VisitTwo-Minute Walk TestBaseline84.4 meters
Home and Phone VisitTwo-Minute Walk Test12-Week83.3 meters
Home and Phone VisitTwo-Minute Walk Test24-Week84.0 meters
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.75Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.11Mixed Models Analysis
Secondary

World Health Organization Disability Assessment Scale

Scores ranging from 1 (no difficulty) to 5 (extreme difficulty/cannot do). Overall disability was calculated by summing the scores for the 12 items; higher scores indicated greater disability (score range: 12-60).

Time frame: Baseline, 12 weeks, and 24 weeks

Population: 38 (35 men, 3 women; 19 INT, 19 CTL) enrolled. 1 INT and 1 CTL lost to follow-up. 36 participants assessed at all time points. Two CTL at 12 weeks and 2 CTL,1 INT at 24 weeks completed questionnaires only.

ArmMeasureGroupValue (MEAN)
Exercise, Activity, and Self-managementWorld Health Organization Disability Assessment ScaleBaseline26.2 units on a scale
Exercise, Activity, and Self-managementWorld Health Organization Disability Assessment Scale12-Week24.2 units on a scale
Exercise, Activity, and Self-managementWorld Health Organization Disability Assessment Scale24-Week21.6 units on a scale
Home and Phone VisitWorld Health Organization Disability Assessment ScaleBaseline27.5 units on a scale
Home and Phone VisitWorld Health Organization Disability Assessment Scale12-Week25.3 units on a scale
Home and Phone VisitWorld Health Organization Disability Assessment Scale24-Week25.3 units on a scale
Comparison: Test null hypothesis that there is no difference between groups from baseline to 12-week test.p-value: 0.96Mixed Models Analysis
Comparison: Test null hypothesis that there is no difference between groups from baseline to 24-week test.p-value: 0.35Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026